Chelerythrine

CAS No. 34316-15-9

Chelerythrine( —— )

Catalog No. M18448 CAS No. 34316-15-9

Chelerythrine is a well-known protein kinase C inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 77 In Stock
25MG 131 In Stock
50MG 195 In Stock
100MG 293 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chelerythrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Chelerythrine is a well-known protein kinase C inhibitor.
  • Description
    Chelerythrine may have antimanic effect . Chelerythrine can inhibit telomerase activity. Chelerythrine is a well-known protein kinase C inhibitor.Chelerythrine has potential antiproliferative and antitumor effects.
  • In Vitro
    Western Blot Analysis Cell Line:A549 and NCI-H1299 cells Concentration:10, 15, 20 μM Incubation Time:24 h Result:Induced expression of LC3-II in a beclin 1-dependent way.
  • In Vivo
    Animal Model:Unilateral ureteral obstruction (UUO) induced neonatal ratsDosage:5 mg/kg Administration:i.p., daily Result:Attenuated kidney injury (Increased kidney weight and restored renal function).Inhibited UUO-induced upregulated kidney injury molecule-1 expression, apoptosis, and renal fibrosis.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    34316-15-9
  • Formula Weight
    348.37
  • Molecular Formula
    C21H18NO4+
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC5=C(C=C42)OCO5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Doxofylline

    Doxofylline is a phosphodiesterase inhibitor and a xanthine derivative drug for asthma.

  • PDE4B-IN-2

    PDE4B-IN-2 (A 33) is an orally active and selective PDE4B inhibitor with an IC50 of 15 nM. PDE4B-IN-2 inhibits PDE4D (IC50=1.7 μM).

  • LJI308

    LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.